Literature DB >> 24501392

Getting more out of survival data by using the hazard function.

Kenneth R Hess1, Victor A Levin.   

Abstract

Information about the survival experience for a group of patients is almost exclusively conveyed using plots of the survival function. However, the hazard function provides information about the survival experience that is not readily evident from inspection of the survival function. The hazard function tracks the instantaneous failure rate over time among the surviving patients and can be readily estimated with available software. We illustrate how these estimates can be used in conjunction with estimates of the survival function to glean clinically relevant information from survival data. ©2014 AACR.

Entities:  

Mesh:

Year:  2014        PMID: 24501392     DOI: 10.1158/1078-0432.CCR-13-2125

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  11 in total

1.  Beneficial Effect of Adjuvant Dabrafenib Plus Trametinib on Recurrence-Free Survival in Patients With Resected BRAFV600-Mutant Stage III Melanoma Seems to be Short-Lived.

Authors:  Kenneth R Hess
Journal:  J Clin Oncol       Date:  2019-04-02       Impact factor: 44.544

2.  Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype.

Authors:  W Fraser Symmans; Caimiao Wei; Rebekah Gould; Xian Yu; Ya Zhang; Mei Liu; Andrew Walls; Alex Bousamra; Maheshwari Ramineni; Bruno Sinn; Kelly Hunt; Thomas A Buchholz; Vicente Valero; Aman U Buzdar; Wei Yang; Abenaa M Brewster; Stacy Moulder; Lajos Pusztai; Christos Hatzis; Gabriel N Hortobagyi
Journal:  J Clin Oncol       Date:  2017-01-30       Impact factor: 44.544

3.  Impact of severe postoperative inflammatory response on recurrence after curative resection of colorectal cancer.

Authors:  Yuya Nakamura; Tadayoshi Yamaura; Yousuke Kinjo; Makoto Kawase; Satoshi Kanto; Nobukazu Kuroda
Journal:  Int J Colorectal Dis       Date:  2022-10-24       Impact factor: 2.796

4.  Conditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-Mutation.

Authors:  Yoshikuni Kawaguchi; Heather A Lillemoe; Elena Panettieri; Yun Shin Chun; Ching-Wei D Tzeng; Thomas A Aloia; Scott Kopetz; Jean-Nicolas Vauthey
Journal:  J Am Coll Surg       Date:  2019-05-02       Impact factor: 6.113

5.  A matched cohort study of the failure pattern after laparoscopic and open gastrectomy for locally advanced gastric cancer: does the operative approach matter?

Authors:  Jun Lu; Dong Wu; Bin-Bin Xu; Zhen Xue; Hua-Long Zheng; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Ping Li; Chao-Hui Zheng; Chang-Ming Huang
Journal:  Surg Endosc       Date:  2021-02-16       Impact factor: 4.584

6.  Describing the association between socioeconomic inequalities and cancer survival: methodological guidelines and illustration with population-based data.

Authors:  Aurélien Belot; Laurent Remontet; Bernard Rachet; Olivier Dejardin; Hadrien Charvat; Simona Bara; Anne-Valérie Guizard; Laurent Roche; Guy Launoy; Nadine Bossard
Journal:  Clin Epidemiol       Date:  2018-05-17       Impact factor: 4.790

7.  Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma.

Authors:  Xin Liu; Tao Wu; Su-Yu Zhu; Mei Shi; Hang Su; Ying Wang; Xia He; Li-Ming Xu; Zhi-Yong Yuan; Li-Ling Zhang; Gang Wu; Bao-Lin Qu; Li-Ting Qian; Xiao-Rong Hou; Fu-Quan Zhang; Yu-Jing Zhang; Yuan Zhu; Jian-Zhong Cao; Sheng-Min Lan; Jun-Xin Wu; Shu-Nan Qi; Yong Yang; Ye-Xiong Li
Journal:  JAMA Netw Open       Date:  2019-03-01

8.  Conditional Survival and Annual Hazard Estimates of Classical Hodgkin Lymphoma.

Authors:  Reyizha Nuersulitan; Mingzi Yang; Lan Mi; Meng Wu; Xin Liu; Lingyan Ping; Yan Xie; Weiping Liu; Yuqin Song; Jun Zhu
Journal:  Cancer Manag Res       Date:  2021-08-26       Impact factor: 3.989

Review 9.  Clinical importance of eflornithine (α-difluoromethylornithine) for the treatment of malignant gliomas.

Authors:  Victor A Levin; Sandra E Ictech; Kenneth R Hess
Journal:  CNS Oncol       Date:  2018-01-30

10.  Prognostic impact of preoperatively elevated and postoperatively normalized carcinoembryonic antigen levels following curative resection of stage I-III rectal cancer.

Authors:  Yuya Nakamura; Dai Shida; Taro Tanabe; Yasuyuki Takamizawa; Jun Imaizumi; Yuka Ahiko; Ryohei Sakamoto; Konosuke Moritani; Shunsuke Tsukamoto; Yukihide Kanemitsu
Journal:  Cancer Med       Date:  2019-12-04       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.